首页 > 最新文献

Life-Basel最新文献

英文 中文
Preserflo MicroShunt versus Trabeculectomy: Efficacy and Surgical Success within a Heterogenous Patient Cohort. Preserflo 微分流术与小梁切除术:异质患者群的疗效和手术成功率。
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-17 DOI: 10.3390/life14091171
Lynn Anna Barbara Zweifel, Jens Julian Storp, Friederike Elisabeth Vietmeier, Moritz Fabian Danzer, Ralph-Laurent Merté, Nicole Eter, Viktoria Constanze Brücher

To compare success rates of trabeculectomy (TE) and Preserflo MicroShunt (PMS) in heterogenous glaucoma cohorts with regards to different pre- and postoperative therapeutic regimens. Data of 187 glaucoma patients who either received TE (73 eyes) or PMS implantation (114 eyes) between January 2018 and December 2022 were retrospectively evaluated. Surgical success and failure rates were analyzed within six months of follow-up. Intraocular pressure (IOP) development over the course of follow-up was compared between both groups. Tertiary outcome measures were best-corrected visual acuity (BCVA), number and type of medications, frequency of postoperative complications and revision surgeries. Outcome measures underwent additional assessment based on subgroup categorizations, and failure time hazard ratios were computed. The success rates were comparable between both procedures (TE: 54.1%, PMS: 60.0%; p = 0.17). Both procedures showed significant IOP reduction (p < 0.01); however, overall IOP reduction was greater in the TE group than in the PMS group (TE: Reduction by 12 mmHg (188.9%), PMS: Reduction by 7 mmHg (51.3%); p = 0.01). The number of topical medications decreased significantly in both groups over the course of follow-up (TE: 4 to 0, PMS: 3 to 0; p < 0.01). While the number of complications and revision surgeries were similar in both groups, the time interval until the first revision surgery within the TE group was significantly shorter (TE: 13.5 d, PMS: 163 d; p = 0.01) than within the PMS group. No difference could be detected between TE and PMS with regard to the follow-up regimen. In particular, there was no significant difference in the need for 5-floururacil injections postoperatively (p = 0.29). Less invasive glaucoma surgery with the PMS appeared comparable to the TE within a heterogenous glaucoma cohort with regards to IOP development and freedom from medication.

目的:比较异质性青光眼队列中小梁切除术(TE)和Preserflo MicroShunt(PMS)术前术后不同治疗方案的成功率。对2018年1月至2022年12月期间接受TE(73眼)或PMS植入术(114眼)的187名青光眼患者的数据进行了回顾性评估。对随访六个月内的手术成功率和失败率进行了分析。比较了两组患者在随访过程中眼压(IOP)的变化情况。三级结果指标包括最佳矫正视力(BCVA)、用药次数和类型、术后并发症发生频率和翻修手术次数。根据亚组分类对结果指标进行了额外评估,并计算了失败时间危险比。两种手术的成功率相当(TE:54.1%;PMS:60.0%;P = 0.17)。两种手术都能明显降低眼压(p < 0.01);但是,TE 组的总体眼压降低幅度大于 PMS 组(TE:降低 12 mmHg (188.9%),PMS:降低 7 mmHg (51.3%);p = 0.01)。在随访过程中,两组患者的局部用药次数均显著减少(TE:4 次减至 0 次,PMS:3 次减至 0 次;p <0.01)。虽然两组的并发症和翻修手术次数相似,但 TE 组患者首次翻修手术的时间间隔(TE:13.5 d,PMS:163 d;p = 0.01)明显短于 PMS 组。在随访方案方面,TE 组和 PMS 组没有差异。尤其是在术后注射5-氟尿嘧啶的需求方面,两者没有明显差异(P = 0.29)。在异质性青光眼队列中,采用PMS的微创青光眼手术在眼压发展和免于药物治疗方面似乎与TE相当。
{"title":"Preserflo MicroShunt versus Trabeculectomy: Efficacy and Surgical Success within a Heterogenous Patient Cohort.","authors":"Lynn Anna Barbara Zweifel, Jens Julian Storp, Friederike Elisabeth Vietmeier, Moritz Fabian Danzer, Ralph-Laurent Merté, Nicole Eter, Viktoria Constanze Brücher","doi":"10.3390/life14091171","DOIUrl":"https://doi.org/10.3390/life14091171","url":null,"abstract":"<p><p>To compare success rates of trabeculectomy (TE) and Preserflo MicroShunt (PMS) in heterogenous glaucoma cohorts with regards to different pre- and postoperative therapeutic regimens. Data of 187 glaucoma patients who either received TE (73 eyes) or PMS implantation (114 eyes) between January 2018 and December 2022 were retrospectively evaluated. Surgical success and failure rates were analyzed within six months of follow-up. Intraocular pressure (IOP) development over the course of follow-up was compared between both groups. Tertiary outcome measures were best-corrected visual acuity (BCVA), number and type of medications, frequency of postoperative complications and revision surgeries. Outcome measures underwent additional assessment based on subgroup categorizations, and failure time hazard ratios were computed. The success rates were comparable between both procedures (TE: 54.1%, PMS: 60.0%; <i>p</i> = 0.17). Both procedures showed significant IOP reduction (<i>p</i> < 0.01); however, overall IOP reduction was greater in the TE group than in the PMS group (TE: Reduction by 12 mmHg (188.9%), PMS: Reduction by 7 mmHg (51.3%); <i>p</i> = 0.01). The number of topical medications decreased significantly in both groups over the course of follow-up (TE: 4 to 0, PMS: 3 to 0; <i>p</i> < 0.01). While the number of complications and revision surgeries were similar in both groups, the time interval until the first revision surgery within the TE group was significantly shorter (TE: 13.5 d, PMS: 163 d; <i>p</i> = 0.01) than within the PMS group. No difference could be detected between TE and PMS with regard to the follow-up regimen. In particular, there was no significant difference in the need for 5-floururacil injections postoperatively (<i>p</i> = 0.29). Less invasive glaucoma surgery with the PMS appeared comparable to the TE within a heterogenous glaucoma cohort with regards to IOP development and freedom from medication.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in Diagnostic Modalities for Helicobacter pylori Infection. 幽门螺旋杆菌感染诊断方法的进展。
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-17 DOI: 10.3390/life14091170
Haider Ghazanfar, Nismat Javed, Raul Reina, Ornela Thartori, Ali Ghazanfar, Harish Patel

Helicobacter pylori (H. pylori) infection is a widespread global health issue with a varying prevalence influenced by geography, socioeconomic status, and demographics. In the U.S., the prevalence is lower, though certain groups, such as older adults and immigrants from high-prevalence regions, show higher rates. The decrease in infection rates in developed countries is due to improved sanitation, antibiotics, and healthcare, whereas developing countries continue to experience high rates due to poor living conditions. H. pylori infection can be asymptomatic or cause symptoms like dyspepsia, abdominal pain, bloating, nausea, and loss of appetite. Pathophysiologically, H. pylori contribute to conditions such as gastritis, peptic ulcers, and gastric cancer through mechanisms including urease production and the release of virulence factors, leading to chronic inflammation and an increased cancer risk. Diagnostic methods for H. pylori have progressed significantly. Non-invasive techniques, such as serological assays, stool antigen tests, and urea breath tests, are practical and sensitive. Invasive methods, including endoscopic biopsy and molecular diagnostics, are more definitive but resource intensive. Recent advancements in diagnostic technology, including matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), biosensor technology, and next-generation sequencing (NGS), promise improved speed, accuracy, and accessibility. These innovations are expected to enhance the detection and management of H. pylori, potentially reducing the global disease burden. This review aims to discuss these diagnostic modalities with a focus on further advances under investigation.

幽门螺杆菌(H. pylori)感染是一个普遍的全球性健康问题,其流行率受地理位置、社会经济地位和人口统计的影响而各不相同。在美国,幽门螺杆菌感染率较低,但某些群体,如老年人和来自高感染率地区的移民,感染率较高。发达国家感染率下降的原因是卫生条件、抗生素和医疗保健的改善,而发展中国家由于生活条件差,感染率仍然很高。幽门螺杆菌感染可无症状,也可引起消化不良、腹痛、腹胀、恶心和食欲不振等症状。在病理生理学上,幽门螺杆菌通过产生尿素酶和释放毒力因子等机制,导致慢性炎症和癌症风险增加,从而引发胃炎、消化性溃疡和胃癌等疾病。幽门螺杆菌的诊断方法已取得重大进展。血清学检测、粪便抗原检测和尿素呼气检测等非侵入性技术既实用又灵敏。包括内窥镜活检和分子诊断在内的侵入性方法更为明确,但需要大量资源。诊断技术的最新进展,包括基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)、生物传感器技术和下一代测序(NGS),有望提高诊断速度、准确性和可及性。这些创新有望加强幽门螺杆菌的检测和管理,从而减轻全球疾病负担。本综述旨在讨论这些诊断方法,重点关注正在研究的进一步进展。
{"title":"Advances in Diagnostic Modalities for <i>Helicobacter pylori</i> Infection.","authors":"Haider Ghazanfar, Nismat Javed, Raul Reina, Ornela Thartori, Ali Ghazanfar, Harish Patel","doi":"10.3390/life14091170","DOIUrl":"https://doi.org/10.3390/life14091170","url":null,"abstract":"<p><p><i>Helicobacter pylori</i> (<i>H. pylori</i>) infection is a widespread global health issue with a varying prevalence influenced by geography, socioeconomic status, and demographics. In the U.S., the prevalence is lower, though certain groups, such as older adults and immigrants from high-prevalence regions, show higher rates. The decrease in infection rates in developed countries is due to improved sanitation, antibiotics, and healthcare, whereas developing countries continue to experience high rates due to poor living conditions. <i>H. pylori</i> infection can be asymptomatic or cause symptoms like dyspepsia, abdominal pain, bloating, nausea, and loss of appetite. Pathophysiologically, <i>H. pylori</i> contribute to conditions such as gastritis, peptic ulcers, and gastric cancer through mechanisms including urease production and the release of virulence factors, leading to chronic inflammation and an increased cancer risk. Diagnostic methods for <i>H. pylori</i> have progressed significantly. Non-invasive techniques, such as serological assays, stool antigen tests, and urea breath tests, are practical and sensitive. Invasive methods, including endoscopic biopsy and molecular diagnostics, are more definitive but resource intensive. Recent advancements in diagnostic technology, including matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), biosensor technology, and next-generation sequencing (NGS), promise improved speed, accuracy, and accessibility. These innovations are expected to enhance the detection and management of <i>H. pylori</i>, potentially reducing the global disease burden. This review aims to discuss these diagnostic modalities with a focus on further advances under investigation.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11432972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The RING-Type E3 Ligase BOI Interacts with EXO70E2 and Mediates Its Ubiquitination in Arabidopsis. 拟南芥中 RING 型 E3 连接酶 BOI 与 EXO70E2 相互作用并介导其泛素化
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-17 DOI: 10.3390/life14091169
Zhaowu Li, Jianzhong Huang, Yue Hu, Xiaojie Zhou, Xiao Tan, Zhangying Wang, Zhiyong Gao, Xiaoqiu Wu

The exocyst is a hetero-octameric complex that exhibits significant functional diversity in regulating biological processes and defense responses. In plants, the EXO70 proteins are important components of the exocyst complex and are involved in membrane trafficking, biotic and abiotic interactions, as well as cell wall formation. A previous study has indicated that a member of the EXO subfamily, EXO70E2, interacts with RIN4 to mediate plant immunity. In this study, we found that EXO70E2 interacts with the RING-type E3 ligase Botrytis susceptible1 interactor (BOI), and the C-terminal domain of BOI is necessary for its interaction with EXO70E2. Moreover, the protein level of EXO70E2 was degraded and ubiquitinated by BOI in vitro. Collectively, our study reveals a mechanism for regulating the stability of EXO70E2 by a RING-type E3 ligase BOI-mediated ubiquitination.

外囊是一种异八聚体复合体,在调节生物过程和防御反应方面具有显著的功能多样性。在植物中,EXO70 蛋白是外囊复合体的重要组成部分,参与膜运输、生物和非生物相互作用以及细胞壁的形成。之前的一项研究表明,EXO 亚家族的一个成员 EXO70E2 与 RIN4 相互作用,介导植物免疫。在本研究中,我们发现 EXO70E2 与 RING 型 E3 连接酶 Botrytis susceptible1 interactor(BOI)相互作用,而 BOI 的 C 端结构域是其与 EXO70E2 相互作用的必要条件。此外,EXO70E2 的蛋白水平在体外被 BOI 降解和泛素化。总之,我们的研究揭示了一种通过RING型E3连接酶BOI介导泛素化来调节EXO70E2稳定性的机制。
{"title":"The RING-Type E3 Ligase BOI Interacts with EXO70E2 and Mediates Its Ubiquitination in <i>Arabidopsis</i>.","authors":"Zhaowu Li, Jianzhong Huang, Yue Hu, Xiaojie Zhou, Xiao Tan, Zhangying Wang, Zhiyong Gao, Xiaoqiu Wu","doi":"10.3390/life14091169","DOIUrl":"https://doi.org/10.3390/life14091169","url":null,"abstract":"<p><p>The exocyst is a hetero-octameric complex that exhibits significant functional diversity in regulating biological processes and defense responses. In plants, the EXO70 proteins are important components of the exocyst complex and are involved in membrane trafficking, biotic and abiotic interactions, as well as cell wall formation. A previous study has indicated that a member of the EXO subfamily, EXO70E2, interacts with RIN4 to mediate plant immunity. In this study, we found that EXO70E2 interacts with the RING-type E3 ligase Botrytis susceptible1 interactor (BOI), and the C-terminal domain of BOI is necessary for its interaction with EXO70E2. Moreover, the protein level of EXO70E2 was degraded and ubiquitinated by BOI in vitro. Collectively, our study reveals a mechanism for regulating the stability of EXO70E2 by a RING-type E3 ligase BOI-mediated ubiquitination.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11432932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization of Assisted Reproductive Technologies in Breeding Auliekol Cattle: A Comparative Study. 辅助生殖技术在奥利科尔牛育种中的应用:比较研究
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-15 DOI: 10.3390/life14091167
Altyn Kulpiisova, Kairly Yessengaliyev, Gulsara Kassimova, Ainat Kozhakhmetova, Bakytkanym Kadraliyeva, Abeldinov Rustem, Alma Temirzhanova, Nadezhda Burambayeva, Salbak Chylbak-Ool, Elena Pakhomova, Nurzhan Abekeshev, Gulnara Baikadamova, Zhomart Kemeshev, Alexandra Tegza, Arman Issimov, Peter White

This study evaluates the utilization of in vitro embryo production (IVEP) technology for the conservation and breeding of the Auliekol cattle breed, a primary beef breed in Kazakhstan facing population decline due to the cessation of breeding programs and the incursion of transboundary diseases. We assessed the effect of consecutive ovum pick-up (OPU) procedures on oocyte yield and embryo production in Auliekol and Aberdeen Angus cows. A total of 2232 and 3659 oocytes were aspirated from Auliekol and Aberdeen Angus donors, respectively, with significantly higher yields and embryo production observed in Aberdeen Angus cows. The application of a meiotic block using Butyrolactone I (BLI) and subsequent in vitro fertilization (IVF) protocols was employed, with embryo development monitored up to the morula/blastocyst stage. Results indicated that Auliekol cows exhibited lower oocyte recovery, cleavage, and blastocyst rates compared to Aberdeen Angus cows, likely due to genetic characteristics. Despite the challenges, IVEP presents a valuable tool for the preservation and future propagation of the Auliekol breed, highlighting the need for further research to enhance reproductive outcomes and conservation strategies.

本研究评估了体外胚胎生产(IVEP)技术在保护和培育 Auliekol 牛品种方面的应用情况,该品种是哈萨克斯坦的一个主要肉牛品种,由于育种计划的停止和跨境疾病的入侵,该品种的数量正在下降。我们评估了连续取卵(OPU)程序对奥利科尔牛和阿伯丁安格斯牛卵母细胞产量和胚胎产量的影响。从 Auliekol 和 Aberdeen Angus 供体中分别抽取了 2232 和 3659 个卵母细胞,观察到 Aberdeen Angus 奶牛的卵母细胞产量和胚胎产量明显更高。使用丁内酯 I(BLI)进行减数分裂阻断,随后采用体外受精(IVF)方案,监测胚胎发育至小白鼠/囊胚阶段。结果表明,与阿伯丁安格斯奶牛相比,奥利科奶牛的卵母细胞回收率、卵裂率和囊胚率都较低,这可能是遗传特性造成的。尽管面临诸多挑战,IVEP 仍为奥利科尔品种的保存和未来繁殖提供了一个宝贵的工具,突出了进一步研究以提高繁殖结果和保护策略的必要性。
{"title":"Utilization of Assisted Reproductive Technologies in Breeding Auliekol Cattle: A Comparative Study.","authors":"Altyn Kulpiisova, Kairly Yessengaliyev, Gulsara Kassimova, Ainat Kozhakhmetova, Bakytkanym Kadraliyeva, Abeldinov Rustem, Alma Temirzhanova, Nadezhda Burambayeva, Salbak Chylbak-Ool, Elena Pakhomova, Nurzhan Abekeshev, Gulnara Baikadamova, Zhomart Kemeshev, Alexandra Tegza, Arman Issimov, Peter White","doi":"10.3390/life14091167","DOIUrl":"https://doi.org/10.3390/life14091167","url":null,"abstract":"<p><p>This study evaluates the utilization of in vitro embryo production (IVEP) technology for the conservation and breeding of the Auliekol cattle breed, a primary beef breed in Kazakhstan facing population decline due to the cessation of breeding programs and the incursion of transboundary diseases. We assessed the effect of consecutive ovum pick-up (OPU) procedures on oocyte yield and embryo production in Auliekol and Aberdeen Angus cows. A total of 2232 and 3659 oocytes were aspirated from Auliekol and Aberdeen Angus donors, respectively, with significantly higher yields and embryo production observed in Aberdeen Angus cows. The application of a meiotic block using Butyrolactone I (BLI) and subsequent in vitro fertilization (IVF) protocols was employed, with embryo development monitored up to the morula/blastocyst stage. Results indicated that Auliekol cows exhibited lower oocyte recovery, cleavage, and blastocyst rates compared to Aberdeen Angus cows, likely due to genetic characteristics. Despite the challenges, IVEP presents a valuable tool for the preservation and future propagation of the Auliekol breed, highlighting the need for further research to enhance reproductive outcomes and conservation strategies.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From a Cup of Tea to Cardiovascular Care: Vascular Mechanisms of Action. 从一杯茶到心血管护理:血管作用机制。
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-15 DOI: 10.3390/life14091168
Marios Sagris, Panayotis K Vlachakis, Spyridon Simantiris, Panagiotis Theofilis, Maria Gerogianni, Paschalis Karakasis, Konstantinos Tsioufis, Dimitris Tousoulis

Tea consumption is increasingly recognized for its potential benefits to cardiovascular health. This study reviews the available research, concentrating on the major components of tea and their mechanisms of action in the cardiovascular system. Tea is abundant in bioactive compounds, such as flavonoids and polysaccharides, which possess significant antioxidant and anti-inflammatory properties. These compounds play a crucial role in mitigating oxidative stress and inflammation, thereby supporting cardiovascular health. They enhance endothelial function, leading to improved vascular relaxation and reduced arterial stiffness, and exhibit antithrombotic effects. Additionally, regular tea consumption is potentially associated with better regulation of blood pressure, improved cholesterol profiles, and effective blood sugar control. It has been suggested that incorporating tea into daily dietary habits could be a practical strategy for cardiovascular disease prevention and management. Despite the promising evidence, more rigorous clinical trials are needed to establish standardized consumption recommendations and fully understand long-term effects. This review offers a more comprehensive analysis of the current evidence based on endothelium function and identifies the gaps that future research should address.

人们越来越认识到饮茶对心血管健康的潜在益处。本研究回顾了现有的研究,主要集中在茶叶的主要成分及其对心血管系统的作用机制。茶叶中含有丰富的生物活性化合物,如类黄酮和多糖,具有显著的抗氧化和抗炎特性。这些化合物在减轻氧化应激和炎症方面发挥着重要作用,从而支持心血管健康。它们能增强内皮功能,从而改善血管松弛,降低动脉僵硬度,并具有抗血栓作用。此外,经常喝茶还能更好地调节血压,改善胆固醇状况,有效控制血糖。有人认为,将茶纳入日常饮食习惯是预防和控制心血管疾病的实用策略。尽管证据令人鼓舞,但仍需要更严格的临床试验来确定标准化的饮用建议,并充分了解其长期效果。本综述对目前基于内皮功能的证据进行了更全面的分析,并指出了未来研究应解决的差距。
{"title":"From a Cup of Tea to Cardiovascular Care: Vascular Mechanisms of Action.","authors":"Marios Sagris, Panayotis K Vlachakis, Spyridon Simantiris, Panagiotis Theofilis, Maria Gerogianni, Paschalis Karakasis, Konstantinos Tsioufis, Dimitris Tousoulis","doi":"10.3390/life14091168","DOIUrl":"https://doi.org/10.3390/life14091168","url":null,"abstract":"<p><p>Tea consumption is increasingly recognized for its potential benefits to cardiovascular health. This study reviews the available research, concentrating on the major components of tea and their mechanisms of action in the cardiovascular system. Tea is abundant in bioactive compounds, such as flavonoids and polysaccharides, which possess significant antioxidant and anti-inflammatory properties. These compounds play a crucial role in mitigating oxidative stress and inflammation, thereby supporting cardiovascular health. They enhance endothelial function, leading to improved vascular relaxation and reduced arterial stiffness, and exhibit antithrombotic effects. Additionally, regular tea consumption is potentially associated with better regulation of blood pressure, improved cholesterol profiles, and effective blood sugar control. It has been suggested that incorporating tea into daily dietary habits could be a practical strategy for cardiovascular disease prevention and management. Despite the promising evidence, more rigorous clinical trials are needed to establish standardized consumption recommendations and fully understand long-term effects. This review offers a more comprehensive analysis of the current evidence based on endothelium function and identifies the gaps that future research should address.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing of Tracheostomy in ICU Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ICU 患者气管切开术的时机:随机对照试验的系统回顾和元分析》。
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-14 DOI: 10.3390/life14091165
Raffaele Merola, Carmine Iacovazzo, Stefania Troise, Annachiara Marra, Antonella Formichella, Giuseppe Servillo, Maria Vargas

Background: The ideal timing for tracheostomy in critically ill patients is still debated. This systematic review and meta-analysis examined whether early tracheostomy improves clinical outcomes compared to late tracheostomy or prolonged intubation in critically ill patients on mechanical ventilation. Methods: We conducted a comprehensive search of randomized controlled trials (RCTs) assessing the risk of clinical outcomes in intensive care unit (ICU) patients who underwent early (within 7-10 days of intubation) versus late tracheostomy or prolonged intubation. Databases searched included PubMed, Embase, and the Cochrane Library up to June 2023. The primary outcome evaluated was mortality, while secondary outcomes included the incidence of ventilator-associated pneumonia (VAP), ICU length of stay, and duration of mechanical ventilation. No language restriction was applied. Eligible studies were RCTs comparing early to late tracheostomy or prolonged intubation in critically ill patients that reported on mortality. The risk of bias was evaluated using the Cochrane Risk of Bias Tool for RCTs, and evidence certainty was assessed via the GRADE approach. Results: This systematic review and meta-analysis included 19 RCTs, covering 3586 critically ill patients. Early tracheostomy modestly decreased mortality compared to the control (RR -0.1511 [95% CI: -0.2951 to -0.0070], p = 0.0398). It also reduced ICU length of stay (SMD -0.6237 [95% CI: -0.9526 to -0.2948], p = 0.0002) and the duration of mechanical ventilation compared to late tracheostomy (SMD -0.3887 [95% CI: -0.7726 to -0.0048], p = 0.0472). However, early tracheostomy did not significantly reduce the duration of mechanical ventilation compared to prolonged intubation (SMD -0.1192 [95% CI: -0.2986 to 0.0601], p = 0.1927) or affect VAP incidence (RR -0.0986 [95% CI: -0.2272 to 0.0299], p = 0.1327). Trial sequential analysis (TSA) for each outcome indicated that additional trials are needed for conclusive evidence. Conclusions: Early tracheostomy appears to offer some benefits across all considered clinical outcomes when compared to late tracheostomy and prolonged intubation.

背景:重症患者气管切开术的理想时机仍存在争议。这篇系统综述和荟萃分析探讨了在使用机械通气的重症患者中,与晚期气管切开术或延长插管相比,早期气管切开术是否能改善临床疗效。方法:我们对随机对照试验(RCT)进行了全面检索,这些试验评估了重症监护病房(ICU)患者早期(插管后 7-10 天内)与晚期气管切开术或延长插管的临床预后风险。所检索的数据库包括 PubMed、Embase 和 Cochrane Library(截至 2023 年 6 月)。评估的主要结果是死亡率,次要结果包括呼吸机相关肺炎(VAP)发生率、重症监护室住院时间和机械通气持续时间。没有语言限制。符合条件的研究均为对重症患者进行早期与晚期气管切开术或延长插管进行比较的研究,并报告了死亡率。采用针对 RCT 的 Cochrane 偏倚风险工具评估偏倚风险,并采用 GRADE 方法评估证据的确定性。结果:该系统综述和荟萃分析包括 19 项研究性临床试验,涉及 3586 名重症患者。与对照组相比,早期气管切开术可适度降低死亡率(RR -0.1511 [95% CI: -0.2951 to -0.0070],p = 0.0398)。与晚期气管切开术相比,它还缩短了重症监护室的住院时间(SMD -0.6237 [95% CI: -0.9526 to -0.2948],p = 0.0002)和机械通气时间(SMD -0.3887 [95% CI: -0.7726 to -0.0048],p = 0.0472)。然而,与长期插管相比,早期气管切开术并不能显著缩短机械通气时间(SMD -0.1192 [95% CI: -0.2986 to 0.0601],p = 0.1927),也不会影响 VAP 发生率(RR -0.0986 [95% CI: -0.2272 to 0.0299],p = 0.1327)。对每种结果进行的试验序列分析(TSA)表明,需要进行更多试验才能获得确凿证据。结论:与晚期气管切开术和延长插管相比,早期气管切开术似乎在所有考虑的临床结果中都有一定的优势。
{"title":"Timing of Tracheostomy in ICU Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.","authors":"Raffaele Merola, Carmine Iacovazzo, Stefania Troise, Annachiara Marra, Antonella Formichella, Giuseppe Servillo, Maria Vargas","doi":"10.3390/life14091165","DOIUrl":"https://doi.org/10.3390/life14091165","url":null,"abstract":"<p><p><b>Background:</b> The ideal timing for tracheostomy in critically ill patients is still debated. This systematic review and meta-analysis examined whether early tracheostomy improves clinical outcomes compared to late tracheostomy or prolonged intubation in critically ill patients on mechanical ventilation. <b>Methods:</b> We conducted a comprehensive search of randomized controlled trials (RCTs) assessing the risk of clinical outcomes in intensive care unit (ICU) patients who underwent early (within 7-10 days of intubation) versus late tracheostomy or prolonged intubation. Databases searched included PubMed, Embase, and the Cochrane Library up to June 2023. The primary outcome evaluated was mortality, while secondary outcomes included the incidence of ventilator-associated pneumonia (VAP), ICU length of stay, and duration of mechanical ventilation. No language restriction was applied. Eligible studies were RCTs comparing early to late tracheostomy or prolonged intubation in critically ill patients that reported on mortality. The risk of bias was evaluated using the Cochrane Risk of Bias Tool for RCTs, and evidence certainty was assessed via the GRADE approach. <b>Results:</b> This systematic review and meta-analysis included 19 RCTs, covering 3586 critically ill patients. Early tracheostomy modestly decreased mortality compared to the control (RR -0.1511 [95% CI: -0.2951 to -0.0070], <i>p</i> = 0.0398). It also reduced ICU length of stay (SMD -0.6237 [95% CI: -0.9526 to -0.2948], <i>p</i> = 0.0002) and the duration of mechanical ventilation compared to late tracheostomy (SMD -0.3887 [95% CI: -0.7726 to -0.0048], <i>p</i> = 0.0472). However, early tracheostomy did not significantly reduce the duration of mechanical ventilation compared to prolonged intubation (SMD -0.1192 [95% CI: -0.2986 to 0.0601], <i>p</i> = 0.1927) or affect VAP incidence (RR -0.0986 [95% CI: -0.2272 to 0.0299], <i>p</i> = 0.1327). Trial sequential analysis (TSA) for each outcome indicated that additional trials are needed for conclusive evidence. <b>Conclusions:</b> Early tracheostomy appears to offer some benefits across all considered clinical outcomes when compared to late tracheostomy and prolonged intubation.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Effects of Natural Products on Human Diseases. 天然产品对人类疾病的治疗效果。
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-14 DOI: 10.3390/life14091166
Seung-Ho Lee

Natural products have long served as potential sources of therapeutic drugs [...].

长期以来,天然产品一直是治疗药物的潜在来源[...]。
{"title":"Therapeutic Effects of Natural Products on Human Diseases.","authors":"Seung-Ho Lee","doi":"10.3390/life14091166","DOIUrl":"https://doi.org/10.3390/life14091166","url":null,"abstract":"<p><p>Natural products have long served as potential sources of therapeutic drugs [...].</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intravenous Levosimendan versus Inhalational Milrinone in the Management of Pulmonary Hypertension during Adult Cardiac Surgery: A Randomized Clinical Trial. 静脉注射左西孟旦与吸入米力农治疗成人心脏手术期间的肺动脉高压:随机临床试验。
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-14 DOI: 10.3390/life14091164
Panagiotis Ftikos, Georgios Gkantinas, Vlasios Karageorgos, Anna Smirli, Nektarios Kogerakis, Evangelos Leontiadis, Konstantinos Petsios, Theofani Antoniou, Kassiani Theodoraki

Introduction: The perioperative management of patients with pulmonary hypertension (PH) undergoing cardiac surgery is challenging, mainly due to the potential risk of right ventricular failure (RVF). Levosimendan is a calcium-sensitizing agent that has primarily been used in the treatment of decompensated heart failure. However, recently levosimendan has been shown to be an effective and safe therapeutic strategy for patients with pulmonary arterial hypertension and PH associated with left heart disease. The aim of this study was to investigate the potential utility of the preemptive administration of levosimendan in cardiac surgical patients with preexisting PH and to compare its effectiveness with milrinone, which represents an already established therapeutic option in the management of PH during cardiac surgery. Materials and Methods: In this study, 40 adult cardiac surgical patients with PH were randomly assigned to receive either levosimendan intravenously or milrinone via inhalation in a double-blind fashion prior to a cardiopulmonary bypass (CPB). Hemodynamic and echocardiographic parameters were recorded and evaluated before and after the administration of the drugs. Results and Conclusions: The results of this study demonstrated that both levosimendan and milrinone administered before CPB in cardiac surgical patients with PH may offer protective benefits, reducing pulmonary artery pressure and preventing the exacerbation of PH and RVF. Pulmonary vasodilation attributed to levosimendan is of longer duration and greater magnitude compared to pulmonary vasodilation afforded by milrinone.

导言:接受心脏手术的肺动脉高压(PH)患者的围手术期管理具有挑战性,这主要是由于右心室衰竭(RVF)的潜在风险。左西孟旦是一种钙增敏剂,主要用于治疗失代偿性心力衰竭。然而,最近有研究表明,左西孟旦对肺动脉高压和伴有左心疾病的 PH 患者是一种有效而安全的治疗策略。本研究的目的是探讨在心脏手术患者中先期使用左西孟旦的潜在作用,并比较其与米力农的疗效,后者是在心脏手术期间治疗肺动脉高压的成熟治疗方案。材料与方法:在这项研究中,40 名患有 PH 的成人心脏手术患者在心肺旁路(CPB)前被随机分配接受静脉注射左西孟旦或吸入米力农的双盲治疗。记录并评估了用药前后的血流动力学和超声心动图参数。结果和结论:本研究结果表明,在心外科 PH 患者进行 CPB 前服用左西孟旦和米力农可起到保护作用,降低肺动脉压力,防止 PH 和 RVF 恶化。与米力农的肺血管扩张作用相比,左西孟旦的肺血管扩张作用持续时间更长、幅度更大。
{"title":"Intravenous Levosimendan versus Inhalational Milrinone in the Management of Pulmonary Hypertension during Adult Cardiac Surgery: A Randomized Clinical Trial.","authors":"Panagiotis Ftikos, Georgios Gkantinas, Vlasios Karageorgos, Anna Smirli, Nektarios Kogerakis, Evangelos Leontiadis, Konstantinos Petsios, Theofani Antoniou, Kassiani Theodoraki","doi":"10.3390/life14091164","DOIUrl":"https://doi.org/10.3390/life14091164","url":null,"abstract":"<p><p><b>Introduction:</b> The perioperative management of patients with pulmonary hypertension (PH) undergoing cardiac surgery is challenging, mainly due to the potential risk of right ventricular failure (RVF). Levosimendan is a calcium-sensitizing agent that has primarily been used in the treatment of decompensated heart failure. However, recently levosimendan has been shown to be an effective and safe therapeutic strategy for patients with pulmonary arterial hypertension and PH associated with left heart disease. The aim of this study was to investigate the potential utility of the preemptive administration of levosimendan in cardiac surgical patients with preexisting PH and to compare its effectiveness with milrinone, which represents an already established therapeutic option in the management of PH during cardiac surgery. <b>Materials and Methods:</b> In this study, 40 adult cardiac surgical patients with PH were randomly assigned to receive either levosimendan intravenously or milrinone via inhalation in a double-blind fashion prior to a cardiopulmonary bypass (CPB). Hemodynamic and echocardiographic parameters were recorded and evaluated before and after the administration of the drugs. <b>Results and Conclusions:</b> The results of this study demonstrated that both levosimendan and milrinone administered before CPB in cardiac surgical patients with PH may offer protective benefits, reducing pulmonary artery pressure and preventing the exacerbation of PH and RVF. Pulmonary vasodilation attributed to levosimendan is of longer duration and greater magnitude compared to pulmonary vasodilation afforded by milrinone.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433114/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Mesenchymal Stem Cells in Female Infertility Treatment: Protocols and Preliminary Results. 间充质干细胞在女性不孕症治疗中的应用:方案和初步结果
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-13 DOI: 10.3390/life14091161
Sofia Chatzianagnosti, Iasonas Dermitzakis, Paschalis Theotokis, Eleni Kousta, George Mastorakos, Maria Eleni Manthou

Infertility is a global phenomenon that impacts people of both the male and the female sex; it is related to multiple factors affecting an individual's overall systemic health. Recently, investigators have been using mesenchymal stem cell (MSC) therapy for female-fertility-related disorders such as polycystic ovarian syndrome (PCOS), premature ovarian failure (POF), endometriosis, preeclampsia, and Asherman syndrome (AS). Studies have shown promising results, indicating that MSCs can enhance ovarian function and restore fertility for affected individuals. Due to their regenerative effects and their participation in several paracrine pathways, MSCs can improve the fertility outcome. However, their beneficial effects are dependent on the methodologies and materials used from isolation to reimplantation. In this review, we provide an overview of the protocols and methods used in applications of MSCs. Moreover, we summarize the findings of published preclinical studies on infertility treatments and discuss the multiple properties of these studies, depending on the isolation source of the MSCs used.

不孕不育是一种全球性现象,对男性和女性都有影响;它与影响个人全身健康的多种因素有关。最近,研究人员利用间充质干细胞疗法治疗与女性生育有关的疾病,如多囊卵巢综合征(PCOS)、卵巢早衰(POF)、子宫内膜异位症、子痫前期和阿瑟曼综合征(AS)。研究结果表明,间充质干细胞可以增强卵巢功能,恢复患者的生育能力。由于间充质干细胞具有再生作用并参与多种旁分泌途径,因此可以改善生育能力。然而,间充质干细胞的有益作用取决于从分离到再植入所使用的方法和材料。在这篇综述中,我们概述了应用间充质干细胞的方案和方法。此外,我们还总结了已发表的不孕症治疗临床前研究结果,并讨论了这些研究的多种特性,具体取决于所用间充质干细胞的分离来源。
{"title":"Application of Mesenchymal Stem Cells in Female Infertility Treatment: Protocols and Preliminary Results.","authors":"Sofia Chatzianagnosti, Iasonas Dermitzakis, Paschalis Theotokis, Eleni Kousta, George Mastorakos, Maria Eleni Manthou","doi":"10.3390/life14091161","DOIUrl":"https://doi.org/10.3390/life14091161","url":null,"abstract":"<p><p>Infertility is a global phenomenon that impacts people of both the male and the female sex; it is related to multiple factors affecting an individual's overall systemic health. Recently, investigators have been using mesenchymal stem cell (MSC) therapy for female-fertility-related disorders such as polycystic ovarian syndrome (PCOS), premature ovarian failure (POF), endometriosis, preeclampsia, and Asherman syndrome (AS). Studies have shown promising results, indicating that MSCs can enhance ovarian function and restore fertility for affected individuals. Due to their regenerative effects and their participation in several paracrine pathways, MSCs can improve the fertility outcome. However, their beneficial effects are dependent on the methodologies and materials used from isolation to reimplantation. In this review, we provide an overview of the protocols and methods used in applications of MSCs. Moreover, we summarize the findings of published preclinical studies on infertility treatments and discuss the multiple properties of these studies, depending on the isolation source of the MSCs used.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type 2 Diabetes Mellitus and Helicobacter pylori Gastritis in Patients Referred for Endoscopy-A Single-Center Romanian Study. 内镜检查转诊患者中的 2 型糖尿病和幽门螺杆菌胃炎--罗马尼亚单中心研究。
IF 3.2 3区 生物学 Q1 BIOLOGY Pub Date : 2024-09-13 DOI: 10.3390/life14091160
Sabrina-Nicoleta Munteanu, Dragoș Huțanu, Ana-Maria Filip, Andreea Raluca Cozac-Szőke, Simona Mocan, Anca Negovan

Background: Type 2 diabetes mellitus (T2DM) affects up to 10% of adults globally, and its complications can mask the risk of gastrointestinal bleeding or malignancy.

Methods: Our study enrolled 633 endoscopic patients stratified according to T2DM presence (4:1 ratio in favor of the control group).

Results: T2DM patients referred for endoscopy experienced lower prevalence of epigastric pain and heartburn (OR = 0.637/OR = 0.346, p < 0.05). Often being anemic (OR = 2.23, p < 0.001), they had significantly lower hemoglobin (p = 0.001) and serum iron (p = 0.02), but serum cholesterol was higher in non-diabetics. Ulcers, erosions and mucosal hemorrhages were comparable between groups (p < 0.05), although low-dose aspirin use was more prevalent in diabetics (p = 0.000, OR = 2.34). T2DM was associated with the increased frequency of antro-corporal active gastritis (OR = 1.451/OR 1.501), with smokers presenting a higher frequency of active H. pylori infection (OR = 3.37). T2DM predicted anemia (adjusted OR = 1.70) and the absence of gastroesophageal reflux symptoms (adjusted OR = 0.37), but not active H. pylori gastritis or premalignant lesions.

Conclusion: In an endoscopic population, patients with T2DM had lower hemoglobin and serum iron levels. There was an inverse correlation between T2DM and heartburn. H. pylori gastritis and premalignant lesions occurred more frequently in diabetic patients (predominantly pangastritis) before adjusting for age or associated comorbidities, with smoking increasing the risk for active infection.

背景:2型糖尿病(T2DM)影响全球10%的成年人,其并发症可能掩盖胃肠道出血或恶性肿瘤的风险:全球多达10%的成年人患有2型糖尿病(T2DM),其并发症会掩盖消化道出血或恶性肿瘤的风险:我们的研究根据 T2DM 患者的情况对 633 名内镜患者进行了分层(对照组与 T2DM 患者的比例为 4:1):结果:转诊接受内镜检查的T2DM患者上腹痛和烧心的发生率较低(OR = 0.637/OR = 0.346,P < 0.05)。他们经常贫血(OR = 2.23,p < 0.001),血红蛋白(p = 0.001)和血清铁(p = 0.02)明显较低,但血清胆固醇却高于非糖尿病患者。溃疡、糜烂和粘膜出血的发生率在各组之间不相上下(p < 0.05),但糖尿病患者服用小剂量阿司匹林的比例更高(p = 0.000,OR = 2.34)。T2DM与颞前活动性胃炎发生率增加有关(OR = 1.451/OR 1.501),吸烟者幽门螺杆菌感染率更高(OR = 3.37)。T2DM可预测贫血(调整后OR = 1.70)和无胃食管反流症状(调整后OR = 0.37),但不能预测活动性幽门螺杆菌胃炎或癌前病变:结论:在内镜检查人群中,T2DM 患者的血红蛋白和血清铁水平较低。结论:在内镜检查人群中,T2DM 患者的血红蛋白和血清铁水平较低,T2DM 与胃灼热呈反向相关。在调整年龄或相关合并症之前,幽门螺杆菌胃炎和癌前病变在糖尿病患者中发生率更高(主要是胃窦炎),吸烟会增加活动性感染的风险。
{"title":"Type 2 Diabetes Mellitus and <i>Helicobacter pylori</i> Gastritis in Patients Referred for Endoscopy-A Single-Center Romanian Study.","authors":"Sabrina-Nicoleta Munteanu, Dragoș Huțanu, Ana-Maria Filip, Andreea Raluca Cozac-Szőke, Simona Mocan, Anca Negovan","doi":"10.3390/life14091160","DOIUrl":"https://doi.org/10.3390/life14091160","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) affects up to 10% of adults globally, and its complications can mask the risk of gastrointestinal bleeding or malignancy.</p><p><strong>Methods: </strong>Our study enrolled 633 endoscopic patients stratified according to T2DM presence (4:1 ratio in favor of the control group).</p><p><strong>Results: </strong>T2DM patients referred for endoscopy experienced lower prevalence of epigastric pain and heartburn (OR = 0.637/OR = 0.346, <i>p</i> < 0.05). Often being anemic (OR = 2.23, <i>p</i> < 0.001), they had significantly lower hemoglobin (<i>p</i> = 0.001) and serum iron (<i>p</i> = 0.02), but serum cholesterol was higher in non-diabetics. Ulcers, erosions and mucosal hemorrhages were comparable between groups (<i>p</i> < 0.05), although low-dose aspirin use was more prevalent in diabetics (<i>p</i> = 0.000, OR = 2.34). T2DM was associated with the increased frequency of antro-corporal active gastritis (OR = 1.451/OR 1.501), with smokers presenting a higher frequency of active <i>H. pylori</i> infection (OR = 3.37). T2DM predicted anemia (adjusted OR = 1.70) and the absence of gastroesophageal reflux symptoms (adjusted OR = 0.37), but not active <i>H. pylori</i> gastritis or premalignant lesions.</p><p><strong>Conclusion: </strong>In an endoscopic population, patients with T2DM had lower hemoglobin and serum iron levels. There was an inverse correlation between T2DM and heartburn. <i>H. pylori</i> gastritis and premalignant lesions occurred more frequently in diabetic patients (predominantly pangastritis) before adjusting for age or associated comorbidities, with smoking increasing the risk for active infection.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11433160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Life-Basel
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1